RNS Number : 1676Q
Legal & General UCITS ETF PLC
16 June 2020
| Funds |
Date |
ISIN code |
Shares in Issue |
Currency |
Net Asset Value |
NAV/per share Base |
| L&G US Equity UCITS ETF |
16/06/2020 |
IE00BFXR5Q31 |
11767267 |
USD |
137852672.11 |
11.715 |
| L&G UK Equity UCITS ETF |
16/06/2020 |
IE00BFXR5R48 |
1200000 |
GBP |
11108339.12 |
9.257 |
| L&G Global Equity UCITS ETF |
16/06/2020 |
IE00BFXR5S54 |
2900000 |
USD |
32768505.63 |
11.299 |
| L&G Japan Equity UCITS ETF |
16/06/2020 |
IE00BFXR5T61 |
11085000 |
USD |
118487783.49 |
10.689 |
| L&G Europe ex UK Equity UCITS ETF |
16/06/2020 |
IE00BFXR5V83 |
9260988 |
EUR |
98931831.73 |
10.683 |
| L&G Asia Pacific ex Japan Equity UCITS ETF |
16/06/2020 |
IE00BFXR5W90 |
4505639 |
USD |
46242278.87 |
10.263 |
| L&G Clean Water UCITS ETF |
16/06/2020 |
IE00BK5BC891 |
1500000 |
USD |
15682056.67 |
10.455 |
| L&G Artificial Intelligence UCITS ETF |
16/06/2020 |
IE00BK5BCD43 |
5500000 |
USD |
67094968.05 |
12.199 |
| L&G Healthcare Innovation UCITS ETF |
16/06/2020 |
IE00BK5BC677 |
2600000 |
USD |
31821996.59 |
12.239 |
| L&G Pharma Breakthrough UCITS ETF |
16/06/2020 |
IE00BF0H7608 |
2500000 |
USD |
29232593.61 |
11.693 |
| L&G Europe Equity (Responsible Exclusions) UCITS ETF |
16/06/2020 |
IE00BKLTRN76 |
9200000 |
EUR |
93361463.03 |
10.148 |
| L&G US Equity (Responsible Exclusions) UCITS ETF |
16/06/2020 |
IE00BKLWY790 |
57400000 |
USD |
602672332.27 |
10.500 |
| L&G Battery Value-Chain UCITS ETF |
16/06/2020 |
IE00BF0M2Z96 |
13000000 |
USD |
122261211.91 |
9.405 |
| L&G Ecommerce Logistics UCITS ETF |
16/06/2020 |
IE00BF0M6N54 |
5500000 |
USD |
57626512.66 |
10.478 |
| L&G ROBO Global Robotics and Automation UCITS ETF |
16/06/2020 |
IE00BMW3QX54 |
47330616 |
USD |
810502270.92 |
17.124 |
| L&G Cyber Security UCITS ETF |
16/06/2020 |
IE00BYPLS672 |
84436776 |
USD |
1549034886.02 |
18.346 |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
NAVKZGMVZVRGGZZ
